Tyrosine kinase inhibitors possess dramatically improved the prognosis of metastatic renal cell carcinoma (RCC). and b) Mediastinal and upper body progression with no treatment in March 2009; (c and d) tumor shrinkage of 90% relating to RECIST requirements in January 2011 after 10 weeks of Sorafenib; (e and f) steady buy 4382-63-2 disease in January… Continue reading Tyrosine kinase inhibitors possess dramatically improved the prognosis of metastatic renal